Terminal Deletion of 11q with Significant Late-Onset Combined Immune Deficiency

Author： Seppänen Mikko   Koillinen Hannele   Mustjoki Satu   Tomi Mölkänen   Sullivan Kathleen  

Publisher： Springer Publishing Company

ISSN： 0271-9142

Source： Journal of Clinical Immunology, Vol.34, Iss.1, 2014-01, pp. : 114-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Deletion Mapping of Chromosome 1 in Early Onset and Late Onset Breast Tumors – AComparative Study in Eastern India

By Chunder Neelanjana   Mandal Syamsundar   Basu Debasis   Roy Anup   Roychoudhury Susanta   Panda Chinmay Kumar  

Pathology Research and Practice, Vol. 199, Iss. 5, 2003-07 ,pp. : 313-321

Urban & Fischer

Access to resources Recommend Favorite

Late-Onset Glycogen Storage Disease Type 2

By  

Current Molecular Medicine, Vol. 14, Iss. 8, 2014-09 ,pp. : 971-978

Bentham Science Publishers

Access to resources Recommend Favorite

Severe combined immune deficiency in an adenosine deaminase-deficient patient

By Özdemir Öner  

Allergy and Asthma Proceedings, Vol. 27, Iss. 2, 2006-03 ,pp. : 172-174

OceanSide Publications, Inc

Access to resources Recommend Favorite

Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review

By Panani Anna  

Annals of Hematology, Vol. 83, Iss. 3, 2004-03 ,pp. : 153-155

Springer Publishing Company

Access to resources Recommend Favorite

Demographic, Clinical, and Ocular Features in Patients with Late-onset Behçet Disease

By Hazirolan Dicle   Sungur Gulten   Duman Sunay  

Ocular Immunology and Inflammation, Vol. 20, Iss. 2, 2012-04 ,pp. : 119-124

Informa Healthcare

Access to resources Recommend Favorite